Intermolecular, Inc. (NASDAQ:IMI) Upgraded at ValuEngine
ValuEngine upgraded shares of Intermolecular, Inc. (NASDAQ:IMI) from a strong sell rating to a sell rating in a research note published on Monday morning.
Shares of Intermolecular (NASDAQ:IMI) remained flat at $0.93 during mid-day trading on Monday. 50,287 shares of the company’s stock traded hands. The stock has a 50-day moving average price of $0.95 and a 200 day moving average price of $0.95. The firm’s market capitalization is $46.09 million. Intermolecular has a 1-year low of $0.78 and a 1-year high of $1.29.
In other Intermolecular news, major shareholder Lloyd I. Miller III purchased 80,000 shares of the firm’s stock in a transaction that occurred on Thursday, June 22nd. The stock was purchased at an average cost of $0.88 per share, with a total value of $70,400.00. Following the transaction, the insider now owns 70,368 shares in the company, valued at $61,923.84. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Over the last ninety days, insiders have purchased 160,957 shares of company stock valued at $139,280. 15.20% of the stock is owned by corporate insiders.
A hedge fund recently raised its stake in Intermolecular stock. Renaissance Technologies LLC boosted its position in shares of Intermolecular, Inc. (NASDAQ:IMI) by 8.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 826,866 shares of the semiconductor company’s stock after buying an additional 67,666 shares during the period. Renaissance Technologies LLC owned approximately 1.67% of Intermolecular worth $784,000 at the end of the most recent quarter. 38.87% of the stock is owned by institutional investors and hedge funds.
Intermolecular, Inc provides thin film solutions. The Company’s high productivity combinatorial (HPC) platform, which consists of its tempus processing tools, its automated characterization methods, and its Informatics analysis software, is purpose-built for research and development (R&D) using combinatorial process systems.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Stock Ratings for Intermolecular Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intermolecular Inc. and related stocks with our FREE daily email newsletter.